Disease and Disorders Common in Midlife Women Flashcards

1
Q

arthritis

A

-joint-based pain; swelling and restricting movement
-common w increasing age & women
-meno effects incidence & severity
-need good H&P, see sxs pattern

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

rheumatoid arthritis

A

-multiple joints; symmetrical
-progressive; variable with activity
-early morning stiffness >30min
-joint swelling, tenderness, +MCP swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

osteoarthritis

A

-single/multiple; a/symmetrical
-episodic/progressive; with activity
-NO early morning stiffness
-joint swelling, maybe tender, occasional MCP swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

gout/pseudogout

A

-single or few; no symmetry
-episodic, some flare up with activity
-early morning stiffness with flare-ups
-joint swelling, redness, tenderness; occasional MCP swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

OA

A

-60% risk in obese women
-progressive loss of cartilage ->joint fail
-knees, hips, hands
-onset around meno

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

OA tx

A

-wt control/exercise
-devices that offload movement in joints
-tylenol & topical NSAIDs first line
-surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RA

A

-inflammatory arthritis
-peak onset 35-55yo women; 3x more
-perimeno & postmeno –> rheum specialist
-no issues with hormone therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RA tx

A

-methotrexate, hydroxychloroquine, sulfasalazine
-modern biologics, TNF antagonists - abatacept, humira, etc
-goal is remission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

seronegative spondyloarthritis

A

-inflamm back pain, restricted spine
-sensitivity at SI joints; prolonged stiffness w inactivity
-a/w iritis, IBS, tendinopathies, peripheral enthesitis
-MRI & XR changes
-tx NSAID and PT, some biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

psoriatic arthritis

A

-peripheral arthritis
-responds to TNF antagonists
-ab testing usually negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

crystal arthropathies

A

-gout –> monosodium urate crystals
-pseudogout –> calcium pyrophosphate crystals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

depression - predictive factors

A

-hx of depression, premens syndrome, postpartum depression
-menopause transition
-hx of abuse/trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

windows of vulnerability

A

some (not all) women are particularly sensitive to change in the hormone milieu, esp in those experienced premenstrually, during the postpartum period, or during meno transition
-change in sex hormones & metabolism; lifestyle, behaviories, sexuality, QOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

depression expression

A

-CV risk factors - wt, smoking, etc
-Metabolic risk factors
-Severity of VMS
-sleep changes
-ethnicity
-lifestyle
-stressful life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

risk of depressive sxs

A

-25-30% risk in premeno
-45-70% risk in perimeno
-SWAN - hispanic women
-3 studies show increased risk in meno transition
-no hx of depression, greater risk if having significant VMS or life events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

anxiety in midlife

A

-lower QOL regardless of VMS and sleep change
-surge of anxiety late in perimeno vs premeno
-hot flashes <–> anxiety
-PTSD, OCD, panic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

anxiety sxs

A

-irritability
-nervousness
-feeling fearful for no reason

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

estrogen on depression

A

-estrogen causes modulatory effect via neurotransmitter pathways & neural receptors; monoaminergic systems - serotonin & noradrenaline
-ER throughout brain; prefrontal cortex, hippocampus for mood/cognition
-improves tryptophan levels
-can have benefits in prevention during meno transition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

antidepressants

A

-SSRI/SNRI
-beneficial in tx when combined w ET
-good efficacy & tolerability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

thyroid disease

A

-common in women; increase w age
-regulates metabolism
-sxs of hyper/hypo can be confused w meno
-screening recs vary
-circulating iodine + amino acid tyrosine = T3 or T4
-efx on liver, muscle, heart, bone, & CNS

21
Q

hypothyroidism

A

-low production of thyroid hormone
-Hashimoto thyroiditis (x7 times in women at midlife)
-fatigue, lethargy, cold intolerance, wt gain, constipation, dry skin, heavier/longer menses
-TSH testing gold standard; plus free T4 & antithyroperoxidase ab (+Hashimoto)
-tx levothyorxine; 1.6mcg/kg wt based

22
Q

monitoring hypothyroidism

A

-monitor every 6-12mo
-dose change w TSH level in 6-8wk
-med taken early to enhance absorption
-oral estrogen = increase in thyroid-binding globulin (TBG) = lowers FT4

23
Q

subclinical hypothyroidism

A

-high TSH, normal FT4
-increased prevalence with age
-tx is individualized depending on sxs if any

24
Q

hyperthyroidism

A

-prevalence 0.5%
-anxiety, palpitations, lighter/less frequent menses, heat intolerance; mimics meno sxs
-Graves, toxic multinodular goiter, solitary hyperfunctioning (toxic) adenoma
-dx with TSH; if low, check FT4. if normal, check TT3

25
thyroid nodule
-discrete lesion w/in thyroid -high prev in women & elderly; 5% palpable -further eval if seen on US or felt on PE
26
thyroid cancer
-dx'd more in women -incidence 40-50yo ->90% differentiated thyroid ca are papillary or follicular -tx management w endo -no screening in asymptomatic adults per USPSTF
27
gallbladder disease
-2x in women than in men -most asymptomatic -RFs: sex, increased parity, age, hormone use, obesity, rapid weight loss -highest incidence in 1) American Indians & 2) Mexican Americans
28
Gallbladder & Hormone Therapy
-exogenous estrogen alone or in combined hormone contraceptives risk developing cholesterol gallstones by increasing hepatic secretion of biliary cholesterol -incr risk cholelithiasis, -cystitis, -cystectomy -oral is worse than transdermal -admin HT w caution in women w hx of chole-
29
STIs
-incr risks (including HIV) with vaginal atrophy -older women need more info than younger; still at risk if sex active -HIV & hep C in certain populations; no routine screening for sexually active postmeno women, based on sex hx -consider expedited partner tx per state recs
30
STIs
-chlamydia trachomatis -neisseria gonorrhoeae -genital herpes (HSV) -human papillomavirus (HPV) -hepatitis B -hepatitis C - HIV -syphilis -vaginal trichomoniasis
31
STI routine screening
-screening for defined populations of asymptomatic women based on age, pregnancy status, or geographic factors, irrespective of personal behaviors or risk factors
32
STI targeted screening
-women who have an increased risk of infection based on personal sexual behaviors (more than 1 sexual partner in the past year; new partner in the past 90 days -factors identified locally, including prevalence of infection in the community, are important
33
STI contact testing
-woman's sexual partner is suspected or known to have chlamydia, gonorrhea, syphilis, HIV, or hep B or C
34
STI coinfection testing
-performed after a woman is dx'd w one STI to find coincident infection with other pathogens -women dx'd w chlamydia, gonorrhea, syphilis, HIV, or primary herpes should be screened for other pathogens -not necessary for women dx'd w recurrent genital warts or recurrent genital herpes -bacterial vaginosis and vaginal candidiasis are not sexually transmitted and are not a reason to perform this test
35
STI diagnostic testing
-should be performed for any woman who, because of s/sxs of infection, is suspected of having an STI
36
chlamydia
-mostly women <25yo -sxs include purulent cervical or vaginal discharge, dysuria, deep dyspareunia, AUB -dx'd w nucleic acid amplification tests; urine testing is okay (picks up 10% less) -test of cure not necessary; rescreen in 3 mo
37
chlamydia tx
-single dose azithromycin 1g PO -doxycycline 100mg BID x7 days PO
38
gonorrhea
-found in cervix, anus, urethra, pharynx, eyes -sxs include pain/burning w urination, vaginal discharge, postcoital, intermenstrual, or postmeno bleeding -dx w nucleic acid amplification tests w vaginal sample -quinolones no longer rec for tx d/t resistance
39
gonorrhea tx
-ceftriaxone 250mg IM + azithromycin 1g PO -single dose cefixime 400mg PO + azithromycin 1g PO
40
genital herpes
-HSV 1 and HSV 2 transmitted by skin-to-skin genital contact; can be caused by asymptomatic shedding -sxs include prodromal burning, itching, & skin hypersensitivity, followed by vesicles or pustules on the vulva, perineum, or rectum, that break and leave tender ulcers -initial infection can take 2-3wks to heal with primary herpes and 7-10days with recurrent herpes -dx with a type-specific herpes culture or a polymerase chain reaction test from active lesion -routine serologic testing not recommended
41
genital herpes tx
-not for cure: antiviral medication during earliest phase of an outbreak can shorten duration, including acyclovir, famciclovir, valacyclovir for -7-10days (initial outbreak) -1-5days (recurrence)
42
human papillomavirus
-causes almost all cervical ca as well as ca of the vagina, vulva, penis, anus, rectum, & oropharynx -genotype 16/18 are high risk for cervical a -genotype 6 & 11 can cause genital warts and low-grade cervical lesions -by age 50yo, at least 80% of US women will have acquired genital HPV infection and most clear it on their own -9 valent vaccine (Gardasil 9) should e given to girls and women age 9-26yo; which has been expanded through 45yo
43
hepatitis B
-concentrated in blood, semen, vaginal secretions, and wound exudates, and is transmitted primarily by percutaneous exposure to blood and sexual contact -10% of adults develop chronic hepatitis (risk for cirrhosis and liver ca) -national strategy for control is through vaccination -screen high-risk persons: HIV positive, injection, drug users, household contacts, or sex partners of positive persons, men who have sex w men, immigrants from geographic regions w prevalence of 2% or more -immunize adults w DM and chronic liver disease
44
hepatitis C
-passed mainly by blood contact (sharing IV drug equipment) -most become chronic, incurring risk of cirrhosis and liver ca -asymptomatic, so anyone born between 1945 and 1965 should be screened -if positive, should be under brief etoh screen and intervention and referral to appropriate services (hepatology)
45
HIV
-16% of people infected w HIV don't know they are infected, so adults between 15-65yo should be screened at least once regardless of risk factors -targeted annual screening: past or present injection drug users, sex partners of HIV-infected persons, men who have sex w men, more than one sex partner -testing is done with 4th gen HIV ag-abcombo testing or 3rd gen ab immunoassay -guidance recommends antiretroviral therapy for all HIV-infected patients to reduce the risk of disease progression and transmission; best done by HIV experienced specialist (ID)
46
syphilis
-caused by treponema pallidum & is considered the "great imitator" bc many of its s/sxs are indistinguishable from those of other diseases -includes: PRIMARY stage (single, painless chancre for 3-6wks); SECONDARY stage (multiple chancres, skin rashes, mucous membrane lesions); LATENT stage (untreated can cause death) -test w rapid plasma regain & confirm by treponemal serum ab test (risk of false positives) -tx: single injection of benzathine penicillin
47
vaginal trichomoniasis
-most curable STI; seen in all ages -caused by trichomonas vaginalis and can involve vagina, endocervix, urethra; 5% may be asymptomatic colonization -sxs include yellow-green or gray vaginal discharge, vulvovaginal irritation & itching, strong unpleasant odor, discomfort w intercourse or urination -dx: saline suspension, POCT, nucleic acid testing -tx: metronidazole or tinidazole single oral dose, tx partners
48
bacterial vaginosis
-not an STI -imbalance in vaginal bacterial flora in which normal lactobacilli are replaced by Gardnerella vaginalis and other anaerobic bacteria -sxs include thin, white, or gray vaginal discharge w a high pH and strong fishy odor -dx: 4 Amsel's criteria = a thin homogenous white vaginal discharge, clue cells accounting for at least 20% of vag epithelial cells on microscopy, pH higher than 4.5, and positive "whiff" test (w KOH or amine test), or POCT probe -tx: metronidazole or clindamycin vag cream, alternative regimens include oral tinidazole and or oral clindamycin
49